Literature DB >> 16432994

The prevalence of liver function abnormalities in pediatric celiac disease patients and its relation with intestinal biopsy findings.

N Arslan1, B Büyükgebiz, Y Oztürk, E Ozer.   

Abstract

UNLABELLED: Abnormal liver function tests and liver damage are seen frequently with celiac disease. However, the pathogenesis of liver functions abnormality is not clearly understood. The aim of this study was to determine the frequency of abnormal liver functions in children with celiac disease and its relation with anthropometric measurements and severity of intestinal damage. PATIENTS AND METHODS: Twenty seven patients with celiac disease were included in the study. Anthropometric and laboratory examinations and intestinal biopsies were performed in all the patients. Mucosal lesions were classified according to the Marsh classification. Villous area, crypt height and mitotic count were measured morphometrically for all biopsy samples.
RESULTS: The mean age of patients was 6 +/- 5 years on admission. Alanine aminotransferase levels were normal (group 1) or elevated (group 2) in 20 and 7 patients, respectively. The mean alanine aminotransferase levels were 22.0 +/- 7.2 in group 1 and 70.5 +/- 31.1 U/L in group 2 patients, (p < 0.001). Complaints, mean age, height for age, weight for height, serum albumin level, villous area, crypt height and mitotic count were not significantly different between the two groups. Similarly, the ratio of Marsh classification was not significantly different between the two groups. All patients were given a gluten-free diet. Serum aminotransferase values returned to normal after 7.4 +/- 2.7 months of a gluten-free diet.
CONCLUSION: Abnormalities of liver functions are frequently seen in paediatric celiac disease patients. These abnormalities are not correlated with malnutrition and severity of intestinal mucosal lesions. Liver enzyme activities return to normal levels in a few months after gluten-free diet.

Entities:  

Mesh:

Year:  2005        PMID: 16432994

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  8 in total

1.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 2.  Celiac disease in children and adolescents: special considerations.

Authors:  Kimberly P Newton; Shereen A Singer
Journal:  Semin Immunopathol       Date:  2012-05-02       Impact factor: 9.623

Review 3.  Liver involvement in pediatric celiac disease.

Authors:  Caterina Anania; Ester De Luca; Giovanna De Castro; Claudio Chiesa; Lucia Pacifico
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

4.  Autoimmune Hepatitis and Celiac Disease: Case Report Showing an Entero-Hepatic Link.

Authors:  Francesco Tovoli; Roberto De Giorgio; Giacomo Caio; Valentina Grasso; Chiara Frisoni; Mauro Serra; Carla Caputo; Vincenzo Stanghellini; Luigi Bolondi; Roberto Corinaldesi; Umberto Volta
Journal:  Case Rep Gastroenterol       Date:  2010-10-26

Review 5.  Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.

Authors:  Albert J Czaja; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

Review 6.  Pathogenesis and clinical significance of liver injury in celiac disease.

Authors:  Umberto Volta
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

7.  Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-12-01

8.  Liver pathology in children with newly diagnosed celiac disease.

Authors:  Kamila Agnieszka Kwiatek-Średzińska; Katarzyna Kondej-Muszyńska; Mirosława Uścinowicz; Irena Werpachowska; Maria Sobaniec-Łotowska; Dariusz Lebensztejn
Journal:  Clin Exp Hepatol       Date:  2019-04-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.